Pilot study demonstrates safety of diabetes medication for patients with Alzheimer's disease

A pilot study suggests the diabetes medication pioglitazone is generally well tolerated and may warrant further study as a treatment for patients with Alzheimer's disease, according to a report posted online today that will appear in the January 2011 print issue of Archives of Neurology.

Read the whole article on Physorg

More from Physorg